Michael Hughes

Michael Hughes

Auto-generated profile, based on publicly available information

Michael Hughes

Virginia Tech, Blacksburg, VA, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SFSusan A. Fiscus
Susan A. Fiscus
SCSusan Cu-Uvin
Susan Cu-Uvin
AEAbel Tilahun Eshete
Abel Tilahun Eshete
MHMichael D. Hughes
Michael D. Hughes
YBYajing Bao
Yajing Bao
JFJanice M. Fritsche
Janice M. Fritsche
Background. Combination antiretroviral therapy (cART) reduces genital tract human immunodeficiency virus type 1 (HIV-1) load and reduces the risk of sexual transmission, but little is known about the efficacy of cART for decreasing genital tract viral load (GTVL) and differences in sex or HIV-1 subtype. Methods. HIV-1 RNA from blood plasma, seminal plasma, or cervical wicks was quantified at baseline and at weeks 48 and 96 after entry in a randomized clinical trial of 3 cART regimens. Results. One hundred fifty-eight men and 170 women from 7 countries were studied (men: 55% subtype B and 45% subtype C; women: 24% subtype B and 76% subtype C). Despite similar baseline CD4+ cell counts and blood plasma viral loads, women with subtype C had the highest GTVL (median, 5.1 log10 copies/mL) compared to women with subtype B and men with subtype C or B (4.0, 4.0, and 3.8 log10 copies/mL, respectively; P < .001). The proportion of participants with a GTVL below the lower limit of quantification (LLQ) at week 48 (90%) and week 96 (90%) was increased compared to baseline (16%; P < .001 at both times). Women were significantly less likely to have GTVL below the LLQ compared to men (84% vs 94% at week 48, P = .006; 84% vs 97% at week 96, P = .002), despite a more sensitive assay for seminal plasma than for cervical wicks. No difference in GTVL response across the 3 cART regimens was detected. Conclusions. The female genital tract may serve as a reservoir of persistent HIV-1 replication during cART and affect the use of cART to prevent sexual and perinatal transmission of HIV-1.

27 October 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
DSDavey M. Smith
Davey M. Smith
JLJonathan Z. Li
Jonathan Z. Li
CMCarlee Moser
Carlee Moser
EYEunice Yeh
Eunice Yeh
JCJudith S. Currier
Judith S. Currier
WEWilliam Erhardt
William Erhardt
Recurrence of symptoms after finishing treatment for COVID-19 with nirmatrelvir-ritonavir (Paxlovid) has become increasingly recognized.1-3 The biological underpinning of this phenomenon is unclear, and its etiology may be multifactorial, including rapid clearance of nirmatrelvir coupled with delayed immune responses or possible development of drug resistance.1-3 The contribution of treatment to symptom rebound needs to be differentiated from symptom rebound that might occur during the natural history of COVID-19. In this cohort study, we sought to determine how often COVID-19 symptoms recurred when the disease was untreated.

30 June 2022 in Public Opinion Quarterly
Verified
Journal Article
Closed access
ARAshley Reichelmann
Ashley Reichelmann
JRJ Micah Roos
J Micah Roos
MHMichael Hughes
Michael Hughes
Public opinion polls frequently demonstrate that the American debate on reparations for slavery falls along racial lines. However, less attention has been paid to how social psychological factors such as views of deservingness mediate that relationship. This manuscript highlights how identity, deservingness, and views of justice affect attitudes about symbolic reparations—a step that many believe is necessary to achieve closure and pave a path for racial equality. Using survey data from an opt-in sample, we demonstrate how both in-group pride and myths of undeservingness of Black Americans function through racial identity to uniquely affect a respondent’s understanding of the lasting harms of slavery. Increases in pride result in opposition to symbolic reparations among white Americans, but they lead to support among Black Americans and Latinx Americans. Racial/ethnic pride has no impact on support for such reparations among Asian Americans. We find that agreement with myths of Black Americans’ undeservingness largely explains the effect of pride among white Americans but not among racialized minority groups, and we argue that this is largely due to the socio- historical context of their identities. We conclude by discussing the implications this has for reparations as a form of justice 155 years after formal slavery ended in the United States.

31 August 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MGMark J Giganti
Mark J Giganti
KCKara W Chew
Kara W Chew
JEJoseph J Eron
Joseph J Eron
JLJonathan Z Li
Jonathan Z Li
MPMauricio Pinilla
Mauricio Pinilla
SAStacey Adams
Stacey Adams
There is little information regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA as a predictor for clinical outcomes in outpatients with mild-to-moderate coronavirus disease 2019 (COVID-19). Anterior nasal (AN) and plasma SARS-CoV-2 RNA data from 2115 nonhospitalized adults who received monoclonal antibodies (mAbs) or placebo in the ACTIV-2/A5401 trial were analyzed for associations with hospitalization or death. One hundred two participants were hospitalized or died through 28 days of follow-up. Higher day 0 (pretreatment) AN RNA was associated with increasing risk of hospitalization/death (risk ratio [RR], 1.24 per log10 copies/mL [95% confidence interval {CI}, 1.04–1.49]) among placebo recipients, ranging from 3% to 16% for <2 to ≥6 log10 copies/mL. Although only 1% had quantifiable levels, there was a similar trend across day 0 plasma RNA categories. Higher day 3 AN RNA was associated with subsequent hospitalization/death among placebo recipients (RR, 1.42 per log10 copies/mL [95% CI, 1.00–2.03]), but not mAb recipients (RR, 1.02 per log10 copies/mL [95% CI, 0.68–1.56]). The proportion of treatment effect (reduction in hospitalizations/deaths after day 3 for mAb vs placebo) explained by day 3 AN RNA was 8%. SARS-CoV-2 RNA levels are predictive of hospitalization/death in the natural history setting, but AN RNA levels may not be a reliable surrogate marker of mAb treatment effect in COVID-19 trials. Clinical Trials Registration. NCT04518410.

20 September 2013 in American Journal of Industrial Medicine
Verified
Journal Article
Open access
PDF file
DGDenise M. Gaughan
Denise M. Gaughan
DCDavid C. Christiani
David C. Christiani
MHMichael D. Hughes
Michael D. Hughes
DBDorothee M. Baur
Dorothee M. Baur
LKLester Kobzik
Lester Kobzik
SKStefanos N. Kales
Stefanos N. Kales
Background: To assess the association between markers of systemic inflammation and pulmonary function in a population of structural firefighters.Methods: We studied male career members of a large Midwestern fire department with questionnaires, spirometry, and high‐sensitivity C‐reactive protein (hsCRP) as a biomarker of systemic inflammation. We examined percent predicted forced expiratory volume in 1 s (FEV1%‐predicted) and forced vital capacity (FVC%‐predicted).Results: Complete data were available for 401 firefighters. Higher hsCRP levels were associated with lower lung function values, after adjusting for confounding variables. Specifically, for every twofold increase in log10‐hsCRP, FEV1%‐predicted decreased by a mean 1.5% (95% CI: 0.4, 2.6%) and FVC%‐predicted decreased by a mean 1.4% (95% CI: 0.4, 2.3%).Conclusion: hsCRP as a biomarker of systemic inflammation may indicate reduced lung function in structural firefighters. Am. J. Ind. Med. 57:31–37, 2014.

9 January 2016
Verified
Book Chapter
Closed access
KKK. Jill Kiecolt
K. Jill Kiecolt
HMHans Momplaisir
Hans Momplaisir
MHMichael Hughes
Michael Hughes
This chapter uses identity theory to generate new hypotheses regarding racial discrimination and depressive symptoms. First, identity theory and social identity theory make opposite predictions that more positive ingroup identity meanings will either magnify or buffer, respectively, the effect of racial discrimination on depressive symptoms. Second, identity theory and the internalized racism perspective make opposite predictions that racial discrimination will either buffer or magnify, respectively, the effect of more negative identity meanings on depressive symptoms. Data on African Americans and Afro-Caribbeans came from the National Survey of American Life. Scales were constructed to measure positive and negative identity meanings and racial discrimination. Positive and negative identity meanings did not interact with racial discrimination to influence depressive symptoms. However, viewing one’s ingroup as more intelligent buffered the adverse effect of being treated by others as if they thought one was not smart. We discuss how the findings inform identity theory.